Discussions on North Korea’s military arsenal -nuclear and conventional- has been headline news, particularly with threats coming from the Hermit Kingdom of missile launches towards Guam. North Korea’s...

NanoBio Corporation today announced the progression of a novel intranasal anthrax vaccine into a pre-clinical IND-enabling toxicology study funded by the U.S. National Institute of Health’s National...

Professor at Laboure College in Milton, MA and biodefense and bioterrorism researcher, Lawrence Roberge PhD joined me to discuss a number of topics in the area of bioterrorism such as a review of the...

We all love a good book and on the Outbreak News This Week Radio Show, I spend most of the hour discussing a fantastic new book on infectious diseases, outbreaks, epidemiologic investigations and not...

It is not just a matter of time when the biological terrorism will hit our world with no mercy.  It is also a matter of choice what agent we will be attacked with. There are no right or wrong pathogens...

CSRA Inc. today announced that a plague vaccine being developed by its subsidiary, DynPort Vaccine Company LLC (DVC), was granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA). DVC...

GENETIC ENGINEERING AND BIOTERRORISM “In warfare there are no constant conditions. He, who can modify his tactics in relation to his opponent, will succeed and win. “ Sun Tzu The biological weapons...

Last week, Gaithersburg, MD based biopharmaceutical company, Emergent BioSolutions Inc. announced the signing of a nearly $1 billion contract with the Centers for Disease Control and Prevention (CDC)...

Scientists are gaining an insider’s look behind the notorious infectivity of Francisella tularensis. This bacterium is an equal opportunity pathogen. It causes the disease tularemia in humans, rabbits...

An Ebola vaccine will take the next critical steps in development under a $24.75 million contract through May 2020 between the U.S. Department of Health and Human Services’ Office of the Assistant...